{"disease":{"id":"japanese-healthy-adult-male-participants","name":"japanese healthy adult male participants"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02902978","title":"A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"EA Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT03237156","title":"Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT03042299","title":"A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Takeda","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}